Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam HCl CGM study in Type 2 Diabetes
NCT00993824Phase 3Completed
- Sponsor
- HealthPartners Institute
- Start
- Sep 2009
- Primary completion
- Sep 2011
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of colesevelam in type 2 diabetes mellitus (T2DM), sponsored by HealthPartners Institute. Started Sep 2009; status: completed.
02
Drugs
colesevelam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00993824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00993824.